Search Results

There are 80134 results for: content related to: Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques

  1. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma


    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  2. You have free access to this content
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma


    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  3. Radioembolization for Hepatocellular Carcinoma: Statistical Confirmation of Improved Survival in Responders by Landmark Analyses


    Accepted manuscript online: 18 AUG 2017, Ahsun Riaz, Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, Ali Alasadi, Ronald Mora, Laura Kulik, Kush Desai, Bartley Thornburg, Samdeep Mouli, Ryan Hickey, Frank H Miller, Vahid Yaghmai, Daniel Ganger, Robert J Lewandowski and Riad Salem

    DOI: 10.1002/hep.29480

  4. You have free access to this content
    A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma


    Volume 121, Issue 10, May 15, 2015, Pages: 1620–1627, Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Alex Aspinall, Kelly W. Burak, Neesha Dhani, Eric Chen, Mehrdad Sinaei, Glen Lo, Tae Kyoung Kim, Patrik Rogalla, Oliver F. Bathe and Jennifer J. Knox

    Version of Record online : 6 JAN 2015, DOI: 10.1002/cncr.29227

  5. mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

    Liver International

    Volume 37, Issue 7, July 2017, Pages: 1047–1055, Tim Meyer, Daniel H. Palmer, Ann-Lii Cheng, Julia Hocke, Arsène-Bienvenu Loembé and Chia-Jui Yen

    Version of Record online : 2 FEB 2017, DOI: 10.1111/liv.13359

  6. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma


    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  7. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study

    Journal of Magnetic Resonance Imaging

    Volume 42, Issue 4, October 2015, Pages: 981–989, Nima Kokabi, Juan C. Camacho, Minzhi Xing, Faramarz Edalat, Pardeep K. Mittal and Hyun S. Kim

    Version of Record online : 12 FEB 2015, DOI: 10.1002/jmri.24845

  8. Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 305–312, Chang Joon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim and Min-Ji Kim

    Version of Record online : 25 JUL 2013, DOI: 10.1111/liv.12270

  9. You have free access to this content
    AASLD Abstracts


    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  10. You have free access to this content
    Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib


    Volume 58, Issue 5, November 2013, Pages: 1655–1666, Michael Vouche, Laura Kulik, Rohi Atassi, Khairuddin Memon, Ryan Hickey, Daniel Ganger, Frank H. Miller, Vahid Yaghmai, Michael Abecassis, Talia Baker, Mary Mulcahy, Ritu Nayar, Robert J. Lewandowski and Riad Salem

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26487

  11. Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

    The Oncologist

    Volume 19, Issue 4, April 2014, Pages: 394–402, Maxime Ronot, Mohamed Bouattour, Johanna Wassermann, Onorina Bruno, Chantal Dreyer, Béatrice Larroque, Laurent Castera, Valérie Vilgrain, Jacques Belghiti, Eric Raymond and Sandrine Faivre

    Version of Record online : 20 MAR 2014, DOI: 10.1634/theoncologist.2013-0114

  12. Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy

    Journal of Surgical Oncology

    Volume 113, Issue 4, March 15, 2016, Pages: 443–448, Olaguoke Akinwande, Prejesh Philips, Charles R. Scoggins, Lawrence Kelly, Cliff Tatum, Mike Hahl, Kelly M. McMasters and Robert C.G. Martin

    Version of Record online : 6 APR 2016, DOI: 10.1002/jso.24141

  13. You have free access to this content
    Hepatology highlights


    Volume 62, Issue 4, October 2015, Pages: 985–987, Jean-François Dufour

    Version of Record online : 29 SEP 2015, DOI: 10.1002/hep.28127

  14. You have free access to this content
    Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy


    Volume 118, Issue 23, 1 December 2012, Pages: 5857–5866, Silvia Stacchiotti, Paolo Verderio, Antonella Messina, Carlo Morosi, Paola Collini, Antonio Llombart-Bosch, Javier Martin, Alessandro Comandone, Jurado Cruz, Andrea Ferraro, Giovanni Grignani, Sara Pizzamiglio, Vittorio Quagliuolo, Piero Picci, Sergio Frustaci, Angelo Paolo Dei Tos, Paolo G. Casali and Alessandro Gronchi

    Version of Record online : 17 MAY 2012, DOI: 10.1002/cncr.27624

  15. You have free access to this content
    Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy


    Volume 60, Issue 1, July 2014, Pages: 192–201, Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan-Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski and Riad Salem

    Version of Record online : 27 MAY 2014, DOI: 10.1002/hep.27057

  16. You have free access to this content
    Characterization of the elongasome core PBP2 : MreC complex of Helicobacter pylori

    Molecular Microbiology

    Volume 82, Issue 1, October 2011, Pages: 68–86, Meriem El Ghachi, Pierre-Jean Matteï, Chantal Ecobichon, Alexandre Martins, Sylviane Hoos, Christine Schmitt, Frédéric Colland, Christine Ebel, Marie-Christine Prévost, Frank Gabel, Patrick England, Andréa Dessen and Ivo G. Boneca

    Version of Record online : 15 SEP 2011, DOI: 10.1111/j.1365-2958.2011.07791.x

  17. You have free access to this content
    mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

    International Journal of Cancer

    Volume 140, Issue 2, 15 January 2017, Pages: 390–399, Wenjun Wang, Wei Bai, Enxin Wang, Yan Zhao, Lei Liu, Man Yang, Hongwei Cai, Dongdong Xia, Lei Zhang, Jing Niu, Zhanxin Yin, Zhuoli Zhang, Daiming Fan, Jielai Xia and Guohong Han

    Version of Record online : 17 OCT 2016, DOI: 10.1002/ijc.30451

  18. You have free access to this content
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy


    Volume 54, Issue 6, December 2011, Pages: 2055–2063, Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, Claudio Zavaglia, Antonio Grieco, Erica Villa, Calogero Cammà, Massimo Colombo and on behalf of the SOFIA (SOraFenib Italian Assessment) study group

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24644

  19. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib

    Hepatology Research

    Volume 44, Issue 13, December 2014, Pages: 1320–1328, Tomokazu Kawaoka, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo and Kazuaki Chayama

    Version of Record online : 24 APR 2014, DOI: 10.1111/hepr.12307

  20. You have full text access to this OnlineOpen article
    Significance of different response evaluation criteria in predicting progression-free survival of lung cancer with certain imaging characteristics

    Thoracic Cancer

    Volume 7, Issue 5, September 2016, Pages: 535–542, Dengxia Yang, Gavitt Woodard, Chan Zhou, Xinyue Wang, Zhujun Liu, Zhaoxiang Ye and Kai Li

    Version of Record online : 21 JUN 2016, DOI: 10.1111/1759-7714.12363